|

Medical Cannabis Clinical Trials

4 actively recruiting trials across 1 location

Also known as: Cannabis oil containing 10% delta-9-tetrahydrocannabinol (THC) and 5% cannabidiol (CBD)

Pipeline

Phase 2: 3

Top Sponsors

  • University of Manitoba1
  • University Medical Center Groningen1
  • Syqe Medical1
  • HealthPartners Institute1

Indications

  • Cancer3
  • Liver Disease1
  • Diabetic Peripheral Neuropathic Pain1
  • Cannabis1
  • Neurodevelopmental Disorders1

Other3 trials

A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients
Phase 2
A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)
Phase 2
Real World Evidence on the Use of Medical Cannabis in Pediatrics

Saint Louis Park, Minnesota1 trial

Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer

HealthPartners Cancer Research Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.